Skip to main content

Dosing, Monitoring, and Reversal of Neuromuscular Blockade: Are Anesthesiologists Following Evidence-Based Practices?

Abstract

Paralysis is an integral component of many balanced anesthetics, and appropriate dosing, monitoring, and reversal of paralytic agents are important aspects of anesthetic care. Recommendations for all three have been well-described in the literature, yet the literature is also replete with evidence that providers often do not follow published guidelines, and that patients suffer with residual paralysis with subsequent serious or catastrophic sequelae. We discuss appropriate evidence-based techniques for dosing, monitoring, and reversal of paralytic agents, and barriers to implementation of best practices.

This is a preview of subscription content, access via your institution.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Bevan DR, Donati F, Kopman AF. Reversal of neuromuscular blockade. Anesthesiology. 1992;77:785–805.

    CAS  Article  Google Scholar 

  2. • Todd MM, Hindman BJ, King BJ. The implementation of quantitative electromyographic neuromuscular monitoring in an academic anesthesia department. Anesth Analg. 2014;119:323–31. Implementation of quantitative neuromuscular blockade monitoring resulted in a significant reduction in the incidence of incompletely reversed patients in the PACU.

  3. • McLean DJ, Diaz-Gil D, Farhan HN, Ladha KS, Kurth T, Eikermann M. Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications. Anesthesiology. 2015;122:1201–13. Study which shows a neuromuscular blocking agent dose dependent association with increased risk of respiratory complications in the postoperative period; and also suggesting that the proper use of neostigmine guided by neuromuscular transmission monitoring results can help eliminate postoperative respiratory complications associated with neuromuscular-blocking agents.

  4. Madsen MV, Staehr-Rye AK, Gatke MR, Claudis C. Neuromuscular blockade for optimising surgical conditions during abdominal and gynaecological surgery: a systemic review. Acta Anaesthesiol Scand. 2015;59:1–16.

    CAS  Article  Google Scholar 

  5. Fuchs-Buder T, Hofmockel R, Geldner G, Diefenbach C, Ulm K, Blobner M. The use of neuromuscular monitoring in Germany. Anaesthesist. 2003;52:522–6.

    CAS  Article  Google Scholar 

  6. Thilen SR, Hansen BE, Ramaiah R, Kent CD, Treggiari MM, Bhananker SM. Intraoperative neuromuscular monitoring site and residual paralysis. Anesthesiology. 2012;117:964–72.

    CAS  Article  Google Scholar 

  7. Grayling M, Sweeney BP. Recovery of neuromuscular blockade: a survey of practice. Anaesthesia. 2007;62:806–9.

    CAS  Article  Google Scholar 

  8. •• Checketts MR, Alladi R, Ferguson K, et al. Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthesists of Great Britain and Ireland. Anaesthesia 2015. Guidelines for UK and Irish anesthetists for physiological monitoring of patients undergoing both sedation and general anaesthesia. Minimum standards for monitoring patients during and in recovery, with new sections discussing the role of monitoring depth of anaesthesia, neuromuscular blockade, and cardiac output.

  9. Sasaki N, Meyer MJ, Malviya SA, Stanislaus AB, MacDonald T, Doran ME, Igumenshcheva A, Hoang AH, Eikermann M. Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study. Anesthesiology. 2014;121:959–68.

    CAS  Article  Google Scholar 

  10. Fuchs-Buder T, Meitelman C, Alla F, Grandjean A, Wuthrich Y, Donati F. Antagonism of low degrees of atracurium-induced neuromuscular blockade. Dose-effect relationships for neostigmine. Anesthesiology. 2010;112:34–40.

    Article  Google Scholar 

  11. Fuchs-Buder T, Baumann C, De Guis J, Guerci P, Meistelman C. Low-dose neostigmine to antagonize shallow atracurium neuromuscular block during inhalational anaesthesia: a randomized controlled trial. Eur J Anaesth. 2013;30:594–8.

    CAS  Article  Google Scholar 

  12. Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg. 2010;111:110–9.

    Article  Google Scholar 

  13. Kopman AF, Eikermann M. Antagonism of non-depolarising neuromuscular block: current practice. Anaesthesia. 2009;64(Suppl 1):22–30.

    CAS  Article  Google Scholar 

  14. Murphy GS, Szokol JW, Marymont JH, et al. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology. 2008;109:389–98.

    Article  Google Scholar 

  15. Murphy GS, Szokol JW, Marymont JH, et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107:130–7.

    Article  Google Scholar 

  16. Debaene B, Plaud B, Dilly M-P, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolorazing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98:1042–8.

    CAS  Article  Google Scholar 

  17. Arbous MS, Meursing AE, van Kleef JW, de Lange JJ, Spoormans HH, Touw P, Werner FM, Grobbee DE. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology. 2005;102:257–68.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roy Soto.

Additional information

This article is part of the Topical Collection on Neuromuscular Blockade.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Asbahi, M., Soto, R. Dosing, Monitoring, and Reversal of Neuromuscular Blockade: Are Anesthesiologists Following Evidence-Based Practices?. Curr Anesthesiol Rep 6, 160–163 (2016). https://doi.org/10.1007/s40140-016-0161-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40140-016-0161-x

Keywords

  • Residual paralysis
  • Neuromuscular blockade
  • Acetylcholinesterase inhibitor